Viewing Study NCT06972758


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-06-25 @ 5:01 AM
Study NCT ID: NCT06972758
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-15
First Post: 2025-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Everolimus in High-Risk Hepatocellular Carcinoma After Curative Resection (SEVERANCE Trial)
Sponsor: Yonsei University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinom View
None Hepatocellular View
Keywords: